Navigation Links
NC Biomanufacturers Supply Defense for World vs. Flu
Date:4/29/2009

Huge GSK, Novartis, Merck plants help define state's economic successes

RESEARCH TRIANGLE PARK, N.C., April 29 /PRNewswire-USNewswire/ -- The global fight against swine flu is shining a spotlight on North Carolina's long-term commitment to biomanufacturing.

Global pharmaceutical giant GlaxoSmithKline, with North American headquarters in Research Triangle Park, is one of the world's two key manufacturers of antiviral flu treatments. GSK makes Relenza at its plant in Zebulon, about 25 miles east of its headquarters campus.

GSK and Swiss drug company Roche, which makes Tamiflu, have notified the World Health Organization that this new strain of the swine-flu virus seems to respond to their medicines.

"When we're called upon to tackle these kinds of disease outbreaks, North Carolina's excellent base of medical research and pharmaceutical manufacturing puts us among global leaders," said E. Norris Tolson, president and CEO of the North Carolina Biotechnology Center.

North Carolina has invested $1.2 billion in steady bioscience growth during the past decade, said Tolson. "Some states aren't so interested in manufacturing. But at times like these, it becomes clear why these science-driven factories are so crucial."

Hundreds of workers at GSK's Zebulon factory have made medicines to supply the world for more than two decades. Meanwhile, Novartis has a flu-vaccine plant under construction at the edge of Holly Springs, about 20 miles southwest of Raleigh.

Read the full story online.

The Biotechnology Center is a private, non-profit corporation supported by the N.C. General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business, education and strategic policy statewide.

Contact: Chris Brodie, vice president of corporate communications, North Carolina Biotechnology Center, chris_brodie@ncbiotech.org or 919-541-9366. Visit the Biotechnology Center's Web site at www.ncbiotech.org.


'/>"/>
SOURCE North Carolina Biotechnology Center
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Hospira Names Brian Meadows Supply Chain Chief
2. Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs
3. Sigma-Aldrich Enters Exclusive Supply Agreement With Gene Oracle to Leverage Its Unique GeneIOS Gene Synthesis Platform
4. New Generation Biofuels Signs Sales Contract with Catoctin Mountain Growers to Supply up to 370,000 gallons of Renewable Biofuel
5. Norgen Biotek Corp. Announces OEM Manufacturing & Supply Agreement with Exiqon A/S
6. SurgiQuest Signs a Development and Supply Agreement with Intuitive Surgical for MIS Access Utilizing the AirSeal(TM) Technology
7. ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical company
8. ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4
9. Poniard Pharmaceuticals Announces Commercial Supply Agreement for Picoplatin
10. Wyeth Names Michael Kamarck President, Technical Operations & Product Supply
11. Health Robotics Announces Contract for its CytoCare(TM) and IV Station(TM) Robots With Arabian Health Care Supply Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Diego, CA (PRWEB) , ... June 27, 2016 , ... ... solutions for clinical trials, announced today the Clinical Reach Virtual Patient Encounter ... their care circle with the physician and clinical trial team. , Using the CONSULT ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. ... the faculty of the University of North Carolina Kenan-Flagler Business School ... entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international efforts, leading ...
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks , ... industrial engineering, was today awarded as one of ... of the world,s most innovative companies. Ginkgo Bioworks ... for the real world in the nutrition, health ... work directly with customers including Fortune 500 companies ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
Breaking Biology Technology:
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
Breaking Biology News(10 mins):